Business
Aimei Health Technology is a Cayman Islands blank-check company seeking a small-cap healthcare target in biopharmaceutical, medical technology, device, diagnostic, or related services markets.
Aimei Health is a healthcare-focused SPAC with only $12.1M left in trust and a May 6, 2026 deal deadline in the filing.
The read at a glance✓ Audited against SEC data
- Business mix — Healthcare-focused blank-check companyNote
- Revenue — No revenue in local bundleNote
- Profitability — Net income was $1.1MNote
- Cash quality — $12.1M held in trustWatch
- Balance sheet — Equity deficit was $4.1MWatch
- Insiders — 0 buys / 0 sellsNote
- Accounting — Going-concern timing riskWatch
Leadership changes
From Aimei Health Technology Co., Ltd.'s own filings, the day they're filed.
- Daniel Veikko Polvi · director · appointmenteff. 2026-06-29
- Julianne Huh · director · departureeff. 2026-06-24
- Junheng Xie · Chief Executive Officer · appointmenteff. 2024-04-19
Latest filings
- 8-K · Company announcement2026-09-03
- 8-K · Company announcement2026-08-25
- 10-Q · Quarterly report2026-08-13
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-08
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Aimei Health Technology Co., Ltd., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.